Try our Advanced Search for more refined results
Illinois
-
February 17, 2026
Bayer AG Unveils $7.3B Deal For Roundup Users
Bayer AG unit Monsanto has agreed to pay up to $7.25 billion over as many as 21 years to resolve current and future claims that exposure to the weed killer Roundup caused non‑Hodgkin lymphoma, under a proposed nationwide class settlement filed Tuesday in Missouri state court in St. Louis.
-
February 13, 2026
States' Generic Drugs Antitrust Case Headed Toward Trial
A Connecticut federal judge has mostly refused to side with pharmaceutical companies facing states' generic drug price-fixing litigation against them, ruling that there are genuine disputes of material fact as to drug distribution chains and the states' antitrust standing and teeing up the case for trial.
-
February 13, 2026
7th Circ. Forces Mercedes 3G Obsolescence Suit Into Arb.
Mercedes-Benz drivers who sued the automaker after its subscription-based roadside assistance and other features became obsolete will have to take their claims to arbitration, the Seventh Circuit ruled on Friday, saying the customers agreed to deal with disputes outside court.
-
February 13, 2026
State AGs Back Senate's Version Of Kids Online Safety Act
Forty state attorneys general have joined in urging Congress to support the U.S. Senate's version of the bipartisan Kids Online Safety Act, a measure that would require online platforms to default to their most protective settings for children.
-
February 13, 2026
State Lawmakers Advance Flurry Of Psilocybin Reform Bills
Since the beginning of the year, lawmakers in several states have introduced and advanced numerous bills regarding psilocybin, the active compound in psychoactive mushrooms, including bills decriminalizing it, funding research into its medical uses and establishing a regulated medical program.
-
February 13, 2026
7th Circ. Wary To Infer American Airlines Uniforms Were Toxic
A Seventh Circuit panel on Friday appeared skeptical of American Airlines workers' argument that it had provided sufficient evidence to infer toxic employee uniforms caused their skin rashes and other symptoms, with one judge suggesting such a broad reading of Illinois law and federal tort doctrine would allow plaintiffs to say "to heck with the experts."
-
February 13, 2026
Dems Say Trump's 3rd Country Removals Are 'Poorly Monitored'
A group of Senate Democrats slammed the Trump administration's "costly, wasteful and poorly monitored" policy to deport noncitizens to places other than their home countries, finding in a report released Friday it's "outsourcing responsibility to governments the United States itself does not trust."
-
February 13, 2026
Indiana AG Declines To Intervene In Posner Wage Suit
Indiana's attorney general has declined to intervene in a pro se plaintiff's suit seeking to revive $170,000 in wage claims against retired Seventh Circuit Judge Richard A. Posner, finding the case did not pose a "substantial" constitutional challenge to a state statute mandating that delayed contracts must be written and signed to be enforced.
-
February 12, 2026
Trump Admin. Blocked From Cutting $600M In Health Funding
An Illinois federal judge on Thursday temporarily blocked the Trump administration from terminating more than $600 million in public health funding to four Democratic-led states, saying the states will likely succeed in showing they are unconstitutionally being targeted due to political or policy objectives.
-
February 12, 2026
Feds Charge 2 Foreign Nationals Over $10M Healthcare Fraud
Federal officials in Chicago announced healthcare fraud charges Thursday against two natives of Pakistan who allegedly made $10 million by using fake medical companies to submit Medicare and other health benefit claims for items and services they never provided.
-
February 12, 2026
7th Circ. Takes Up BIPA Amendment's Retroactivity
The Seventh Circuit heard arguments Thursday over whether a liability-limiting amendment to Illinois' biometric privacy law has retroactive application to lawsuits filed before it took effect, with one judge on the panel saying it seemed like "billions of dollars of consequences turn on how we label the change."
-
February 12, 2026
DC Judge Won't Bow To DOJ, Public Criticism On TPS Ruling
A D.C. federal judge who said she has been receiving threats and personal insults after she temporarily blocked the Trump administration from terminating Temporary Protected Status for Haitians refused to pause her ruling, saying judges will not be intimidated by public threats.
-
February 12, 2026
Trump Admin EV Funding Cuts Suits Merged In Wash. Court
A Washington federal judge has consolidated two lawsuits seeking to stop the Trump administration from preventing nearly $2.5 billion in congressionally appropriated funds from going to electric vehicle charging infrastructure programs.
-
February 12, 2026
HPE Has 'No Grounds' To Hide DOJ Deal Bidders, AGs Say
Democratic attorneys general challenging the controversial Justice Department settlement permitting Hewlett Packard Enterprise's $14 billion purchase of Juniper Networks have urged a California federal judge to let them see who's bidding for assets up for divestiture, arguing the would-be buyers are an integral part of the agreement's viability.
-
February 12, 2026
Ex-Pharma Exec Fights AGs' Quick Win Bid In Antitrust Case
A former pharmaceutical marketing executive urged a Connecticut federal court to reject summary judgment sought against him by state attorneys general pursuing wider price-fixing litigation against most of the generic drug industry, arguing key cooperating witnesses' questionable credibility makes a trial necessary.
-
February 11, 2026
7th Circ. May Seek Ill. Justices' Input In Hyundai BIPA Row
A Seventh Circuit panel on Wednesday appeared skeptical about whether Hyundai Motor America had any control over biometric data captured by cameras installed in certain Hyundai vehicles and how a proposed class of drivers was injured under Illinois' biometric privacy law, but one judge suggested the case presents a question the state's top court may need to answer.
-
February 11, 2026
Biogen Beats Pharmacies' MS Drug Monopoly Suit, For Now
An Illinois federal judge on Wednesday tossed out Walgreens and Kroger's lawsuit accusing Biogen Inc. of illegally stifling competition for its multiple sclerosis drug Tecfidera, but said the standing issues primarily dooming their complaint can likely be cured if they amend their pleading.
-
February 11, 2026
SEC Inks $150K Deal With Adviser In Cherry-Picking Case
The U.S. Securities and Exchange Commission has inked an approximately $150,000 settlement with an investment adviser and his employer over the regulator's accusations of illegal cherry-picking, voluntarily dismissing a parallel suit against the pair months before a trial was set to get underway.
-
February 11, 2026
Big Ten Athletes Back NCAA Campaign Against Prop Bets
Student-athletes in the Big Ten Conference have urged the NCAA to keep fighting to curb prop betting across college athletics, saying it not only threatens the integrity of college sports, but also poses a safety risk.
-
February 11, 2026
Boeing Aims To Nix Polish Airline's $8.4M Damages Report
Boeing has asked a Seattle federal judge to exclude an $8.4 million "eleventh hour" damages report prepared by a Polish airline's expert, arguing it is not only untimely but also irrelevant to testimony the jury will hear.
-
February 11, 2026
HHS Says RFK Jr. Trans Care Policy View Not Legally Binding
Health and Human Services Secretary Robert F. Kennedy Jr.'s declaration supporting the Trump administration's move to cut funding to hospitals that provide gender-affirming care is a nonbinding policy view, his agency told an Oregon federal court, and doesn't trigger provider exclusions from federal health programs.
-
February 11, 2026
7th Circ. Mulls Expiration Date Of Teva, Eli Lilly Patent Deal
Seventh Circuit judges Wednesday pressed counsel for Teva Pharmaceuticals USA Inc. to address how long a settlement under which Eli Lilly & Co. agreed not to block the approval and marketing of Teva's generic version of its osteoporosis drug Forteo could reasonably remain in effect, given Teva's drug wasn't ready for market until years after the underlying patent dispute.
-
February 11, 2026
Ventas, Welltower See Growth Amid Senior Housing Push
Real estate investment trusts Welltower Inc. and Ventas Inc. recorded strong financial results from the last quarter and the full year of 2025, as both companies intensified their focus on senior housing, a sector where they expect to see skyrocketing demand due to demographic trends.
-
February 11, 2026
Schools Must Face Financial Aid Suit Before Appeal: Students
Former students urged an Illinois federal judge to bar Cornell, Georgetown, Notre Dame, MIT and UPenn from going straight to the Seventh Circuit on a ruling that teed up trial against the five schools yet to settle the proposed class action over the alleged fixing of financial aid offerings.
-
February 11, 2026
Paul Hastings Adds Ex-Norton Rose Investment Funds Pro
Paul Hastings LLP has added an investment funds specialist who previously worked with Norton Rose Fulbright as a partner in its Chicago office, the firm announced Wednesday.
Expert Analysis
-
Series
Law School's Missed Lessons: Practical Problem Solving
Issue-spotting skills are well honed in law school, but practicing attorneys must also identify clients’ problems and true goals, and then be able to provide solutions, says Mary Kate Hogan at Quarles & Brady.
-
What Trump Order Limiting State AI Regs Means For Insurers
Last week's executive order seeking to preclude states from regulating artificial intelligence will likely have minimal impact on insurers, but the order and related congressional activities may portend a federal expectation of consistent state oversight of insurers' AI use, says Kathleen Birrane at DLA Piper.
-
4 Privacy Trends This Year With Lessons For Companies
As organizations plan for ongoing privacy law changes, 2025 trends that include a shift of activity from the federal to the state level mean companies should take an adaptive and principle-based approach to privacy programs rather than trying to memorize constantly changing laws, say attorneys at Sheppard Mullin.
-
Opinion
A Uniform Federal Rule Would Curb Gen AI Missteps In Court
To address the patchwork of courts’ standing orders on generative artificial intelligence, curbing abuses and relieving the burden on judges, the federal judiciary should consider amending its civil procedure rules to require litigants to certify they’ve reviewed legal filings for accuracy, say attorneys at Shook Hardy.
-
2025 Noncompete Developments That Led To Inflection Point
Employers must reshape their approaches to noncompete agreements following key 2025 developments, including Delaware's rejection of blue-penciling and the proliferation of state wage thresholds, say attorneys at Gunderson Dettmer.
-
Series
The Law Firm Merger Diaries: Integrating Practice Groups
Enacting unified leadership and consistent client service standards ensures law firm practice groups connect and collaborate around shared goals, turning a law firm merger into a platform for growth rather than a period of disruption, says Brian Catlett at Fennemore Craig.
-
Receivership Law May Streamline Real Estate Sales In Illinois
The Illinois Receivership Act, which goes into effect Jan. 1, provides much-needed clarity on the issue of receivers' sales of commercial real estate and will make the process easier for parties including receivers, special servicers and commercial real estate lenders, say attorneys at Troutman.
-
Opinion
Supreme Court Term Limits Would Carry Hidden Risk
While proposals for limiting the terms of U.S. Supreme Court justices are popular, a steady stream of relatively young, highly marketable ex-justices with unique knowledge and influence entering the marketplace of law and politics could create new problems, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.
-
Next Steps For Orgs. Amid Updated OpenAI Usage Policies
OpenAI's updates to its usage policies, clarifying that its tools are not substitutes for professional medical, legal or other regulated advice, sends a clear signal that organizations should mirror this clarity in their governance policies to mitigate compliance and liability exposure, say attorneys at Baker Donelson.
-
Series
Knitting Makes Me A Better Lawyer
Stretching my skills as a knitter makes me a better antitrust attorney by challenging me to recalibrate after wrong turns, not rush outcomes, and trust that I can teach myself the skills to tackle new and difficult projects — even when I don’t have a pattern to work from, says Kara Kuritz at V&E.
-
How 11th Circ.'s Qui Tam Review Could Affect FCA Litigation
On Dec. 12, the Eleventh Circuit will hear arguments in U.S. ex rel. Zafirov v. Florida Medical Associates, setting the stage for a decision that could drastically reduce enforcement under the False Claims Act, and presenting an opportunity to seek U.S. Supreme Court review of the act's whistleblower provisions, say attorneys at Epstein Becker.
-
Series
The Biz Court Digest: Welcome To Miami
After nearly 20 years in operation, the Miami Complex Business Litigation Division is a pioneer upon which other jurisdictions in the state have been modeled, adopting many innovations to keep its cases running more efficiently and staffing experienced judges who are accustomed to hearing business disputes, say attorneys at King & Spalding.
-
6 Ways To Nuke-Proof Litigation As Explosive Verdicts Rise
As the increasing number of nuclear verdicts continues to reshape the litigation landscape, counsel must understand how to create a multipronged defense strategy to anticipate juror expectations and mitigate the risk of outsize jury awards, say attorneys at Norton Rose.
-
How AI Exec Order May Tee Up Legal Fights With States
The Trump administration's draft executive order would allow it to challenge and withhold federal dollars from states with artificial intelligence laws, but until Congress passes comprehensive AI legislation, states may have to defend their regulatory frameworks in extended litigation, says Charles Mills, a clerk at the U.S. District Court for the Northern District of West Virginia.
-
AI Evidence Rule Tweaks Encourage Judicial Guardrails
Recent additions to a committee note on proposed Rule of Evidence 707 — governing evidence generated by artificial intelligence — seek to mitigate potential dangers that may arise once machine outputs are introduced at trial, encouraging judges to perform critical gatekeeping functions, say attorneys at Lankler Siffert & Wohl.